Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm.
about
Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer.Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development.AvidinOX-anchored biotinylated trastuzumab and pertuzumab induce down-modulation of ErbB2 and tumor cell death at concentrations order of magnitude lower than not-anchored antibodies.Characterization of therapeutic protein AvidinOX by an integrated analytical approach.
P2860
Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Radionuclide Therapy of Unrese ...... nDOTA: Tongue Cancer Paradigm.
@ast
Radionuclide Therapy of Unrese ...... nDOTA: Tongue Cancer Paradigm.
@en
type
label
Radionuclide Therapy of Unrese ...... nDOTA: Tongue Cancer Paradigm.
@ast
Radionuclide Therapy of Unrese ...... nDOTA: Tongue Cancer Paradigm.
@en
prefLabel
Radionuclide Therapy of Unrese ...... nDOTA: Tongue Cancer Paradigm.
@ast
Radionuclide Therapy of Unrese ...... nDOTA: Tongue Cancer Paradigm.
@en
P2093
P2860
P356
P1476
Radionuclide Therapy of Unrese ...... nDOTA: Tongue Cancer Paradigm.
@en
P2093
Antonio Rosi
Barbara Leoni
Cees van Echteld
Claudio Albertoni
Valeria Carollo
Valeria D'Alessio
P2860
P304
P356
10.1089/CBR.2015.1837
P577
2015-07-13T00:00:00Z